Cite
Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling.
MLA
Wang Y, et al. “Inactivation of GSK-3beta by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling.” Diabetes, vol. 58, no. 6, June 2009, pp. 1391–402. EBSCOhost, https://doi.org/10.2337/db08-1697.
APA
Wang Y, Feng W, Xue W, Tan Y, Hein DW, Li XK, Cai L, Wang, Y., Feng, W., Xue, W., Tan, Y., Hein, D. W., Li, X.-K., & Cai, L. (2009). Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling. Diabetes, 58(6), 1391–1402. https://doi.org/10.2337/db08-1697
Chicago
Wang Y, Feng W, Xue W, Tan Y, Hein DW, Li XK, Cai L, et al. 2009. “Inactivation of GSK-3beta by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling.” Diabetes 58 (6): 1391–1402. doi:10.2337/db08-1697.